Polaramine (Polaramine)2mg – 350 tablet

USD $34.05

Each Polaramine contains 2 mg Dexchlorpheniramine 350 tablets. It is used to treat allergic conditions such as hay fever or urticaria.

ATC Classification: R06AB02
Active Ingrediant: Dexchlorpheniramine
Generic Name: Polaramine
Manufacturer: MSD
Strength: 2mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 350 TABLET

Examples of Packages sent


(deks klor fen EER a meen)


Medication Safety Issues

Geriatric Patients: High-Risk Medication:

Beers Criteria: Dexchlorpheniramine, a first-generation antihistamine, is identified in the Beers Criteria as a potentially inappropriate medication to be avoided in patients 65 years and older (independent of diagnosis or condition) due to its potent anticholinergic properties resulting in increased risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity; use should also be avoided due to reduced clearance with advanced age and tolerance associated with use as a hypnotic (Beers Criteria [AGS 2019]).

Pharmacy Quality Alliance (PQA): Dexchlorpheniramine, as a single agent or as part of a combination (excludes OTC products), is identified as a high-risk medication in patients 65 years and older on the PQA?s, Use of High-Risk Medications in the Elderly (HRM) performance measure, a safety measure used by the Centers for Medicare and Medicaid Services (CMS) for Medicare plans (PQA 2017).


Generic Availability: US



Storage and Stability

Store at 20?C to 25?C (68?F to 77?F).


Adverse Reactions

Cardiovascular: Chest tightness

Central nervous system: Ataxia, chills, confusion, convulsions, dizziness, drowsiness (slight to moderate), euphoria, excitement, fatigue, hysteria, insomnia, irritability, nervousness, neuritis, paresthesia, restlessness, sedation, vertigo

Dermatologic: Diaphoresis, skin photosensitivity, skin rash (due to drug), urticaria

Gastrointestinal: Anorexia, constipation, diarrhea, epigastric distress, nausea, vomiting, xerostomia

Genitourinary: Difficulty in micturition, early menses, urinary frequency, urinary retention

Hematologic & oncologic: Agranulocytosis, hemolytic anemia, thrombocytopenia

Hypersensitivity: Anaphylactic shock

Neuromuscular & skeletal: Tremor

Ophthalmic: Blurred vision, diplopia

Otic: Acute labyrinthitis, tinnitus

Respiratory: Dry nose, dry throat, nasal congestion, thickening of bronchial secretions, wheezing

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “Polaramine (Polaramine)2mg – 350 tablet”

Your email address will not be published. Required fields are marked *